Michael W. Schwartz explains the role played by the brain as a cause of elevated blood sugar and related metabolic ...

The US Food and Drug Administration has cleared the Dexcom G7 15-Day Continuous Glucose Monitor (CGM) for people older than ...

A research paper by scientists at The Second Affiliated Hospital of Zhejiang University School of Medicine presented the ...

The U.S. Food and Drug Administration approved DexCom, Inc.’s (NASDAQ:DXCM) Dexcom G7 15-Day Continuous Glucose Monitoring System for people over 18 with diabetes. With an overall Mean Absolute ...

The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.

A group of experts discusses the use of continuous glucose monitoring (CGM) technology in diabetes and its transformative ...

The Food and Drug Administration has cleared diabetes-management firm DexCom's new continuous glucose monitoring (CGM) system ...

DexCom stock was on the rise Thursday after the maker of medical technology said it had received clearance from the U.S. Food ...

Dexcom has won a clearance from the FDA for its longest-lasting continuous glucose monitor, a 15-day version of its flagship ...

The following is a summary of “Comparison of all-cause mortality with different blood glucose control strategies in patients ...